Full-Time

Vice President

Head of In Vivo Pharmacology

Confirmed live in the last 24 hours

Flagship Pioneering

Flagship Pioneering

501-1,000 employees

Biotechnology firm creating health and sustainability solutions

Venture Capital

Senior

Cambridge, MA, USA

Requirements
  • PhD in pharmacology or related discipline
  • 10+ years of pharmaceutical experience
  • Experience in translational research/medicine
  • Deep pharmacology experience
  • Project management skills
  • Experience with IND strategy
  • Ability to work independently and collaboratively
  • Excellent communication skills
Responsibilities
  • Lead, manage, and mentor the in vivo Pharmacology team
  • Ensure leadership and oversight for development and implementation of in vivo preclinical studies
  • Contribute to the design, execution, and analysis of pharmacological studies
  • Develop scientific and technical strategy for projects
  • Integrate data for understanding therapeutic proteins
  • Identify and manage collaborations with CROs and academic labs
  • Execute NHP studies
  • Recognize and develop solutions for scientific issues
  • Design GLP studies for safety/tox determination
  • Explore biomarker hypotheses
  • Implement procedures for sample management
  • Maintain scientific expertise
  • Contribute to building a positive biotech culture

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Stage

N/A

Total Funding

$6.4B

Headquarters

Cambridge, Massachusetts

Founded

2000

Growth & Insights
Headcount

6 month growth

9%

1 year growth

20%

2 year growth

53%